Skip to content
Open access

Risks of Major Adverse Kidney Events in Non-Hispanic Black Patients with Diabetes or Hypertension: A real-world cohort study.

Aug 2026 · American Journal of Nephrology · pp. 1 · 0 citations
Medicine

TL;DR

Across two large cohorts at-risk for CKD, NHB patients experienced higher MAKE risk, shaped by neighborhood social and structural conditions rather than demographic and clinical characteristics alone.

Abstract

INTRODUCTION Chronic kidney disease (CKD) disproportionately burdens non-Hispanic Black (NHB) patients who experience a three- to four-fold higher risk of kidney failure than non-Hispanic White (NHW) individuals. Diabetes and hypertension are the leading causes of CKD, yet the influence of race, social context, and clinical factors on major adverse kidney events (MAKE) remains inadequately understood. This study examined relationships between race, social factors, and MAKE among patients with diabetes or hypertension.

Methods

Electronic health record data from the CURE-CKD Registry (2013-2022) were used to assemble two mutually-exclusive cohorts of NHB and NHW (reference) adults with 1. diabetes (N=375,605) or 2. Hypertension without diabetes (N=710,768). The primary outcome was time to first MAKE, defined as ≥40% decline in estimated glomerular filtration rate (eGFR), eGFR <15 mL/min/1.73 m², kidney failure, dialysis, transplant, or death. Cox proportional hazards models estimated associations between predictors and MAKE. Extreme gradient boosting (XGBoost) machine learning (ML) models were used as a complement to the traditional survival models to evaluate variable relationships with MAKE and compare predictive performance.

Results

NHB patients were younger (diabetes: 56±15 vs. 62±14 years; hypertension: 50±16 vs. 59±16 years), had more prevalent CKD (diabetes: 19% vs. 15%; hypertension: 8% vs. 7%), and had higher adjusted MAKE risk than NHW patients (diabetes: HR=1.07, 95% CI: 1.04-1.11; hypertension: HR=1.10, 95% CI: 1.06-1.14). MAKE occurred in 24% (n=90,910) of the diabetes population over a median (interquartile range) of 4.1 (2.0-6.3) years, and 15% (n=106,209) of the hypertension population over 4.4 (2.4-6.3) years. Non-commercial insurance (Medicaid, Medicare or unclassified insurance [reference: Commercial]), higher social vulnerability index, more frequent hospitalizations, and urban residence were the top predictors of MAKE. XGBoost outperformed Cox models for MAKE prediction and SHapley Additive exPlanations value rankings confirmed key predictors identified in Cox models.

Conclusion

Across two large cohorts at-risk for CKD, NHB patients experienced higher MAKE risk, shaped by neighborhood social and structural conditions rather than demographic and clinical characteristics alone. Integrating social risk assessment, improving guideline-directed testing, and using complementary ML and Cox modeling approaches may enhance early identification of CKD risk, support targeted intervention, and reduce disparities in CKD outcomes.

Read PDF

Similar papers

Open access Aug 2026

Blood Pressure, Kidney Function, and Kidney Mortality Among Mexican Adults.

Elevated BP as a major modifiable risk factor for kidney failure mortality, CKD, and albuminuria is highlighted in this large prospective study in Mexican adults.

Doreen Zhu, P. Kuri-Morales, Rachel Wade et al. · 0 citations
Review Open access Sep 2026

Differential Associations of Social Determinants of Health with Diabetic Kidney Disease and Treatment Targets in Korean Adults with Diabetes.

Background Social determinants of health (SDOH) are linked to adverse diabetes outcomes internationally, but it remains unclear whether these associations are uniform or concentrated across major treatment targets in Korea's universal-coverage setting. Methods We analyzed two Korea National Health and Nutrition Exami...

Yeoree Yang, Kyungdo Han, Y. Lyu et al. · 0 citations
Aug 2026

Phenotypic Heterogeneity of Diabetic Kidney Disease and Its Association With Cardiovascular and Renal Outcomes: Evidence From a Chinese Multicentre Cohort

Diabetic kidney disease exhibits substantial clinical heterogeneity, ranging from the classic proteinuric phenotype to the increasingly recognised nonproteinuric phenotype, but cardiovascular, kidney and all‐cause mortality risks across these phenotypes remain incompletely characterised.

Yi Li, Zuhai Hu, Liping Chen et al. · 0 citations
Open access Sep 2026

Historical Gaps in Kidney and Cardiovascular Risk Assessment Among Patients with Diabetes and Hypertension: A Real-World Primary Care Study.

UACR testing was underutilized among patients with diabetes and hypertension, and consistent screening could have identified individuals who would benefit from guideline directed antiproteinuric therapies.

Jian Roushani, Sachin V. Pasricha, L. Dubrofsky et al. · 0 citations
Review Open access Sep 2026

Specific aspects of kidney care for Africans living in Europe.

Chronic kidney disease (CKD) disproportionately affects people of African ancestry worldwide including those living in Europe and the United States (US), with overrepresentation among those with advanced CKD and kidney failure. This excess burden reflects the convergence of genetic susceptibility, including Apolipoprot...

A. Ramnarine, Ijeoma Uhegbu, Ezigbo Iyamah et al. · 0 citations
Open access Jan 2026

Uncontrolled Hypertension in Cardio‐Renal‐Metabolic Diseases: Real‐World Insights on Patient Profiles and Management Patterns From iCaReMe Global Registry

Background Hypertension (HTN) is a leading risk factor for cardiovascular (CV) and renal morbidity and mortality, yet blood pressure (BP) control remains suboptimal worldwide. Understanding management patterns, especially among patients with coexisting Type 2 diabetes mellitus (T2DM), chronic kidney diseases (CKDs), or...

K. Khunti, M. Arıcı, Carol A. Pollock et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.